NCT00831103View on ClinicalTrials.gov

A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster

PHASE2CompletedINTERVENTIONAL
Enrollment

373

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Herpes Zoster
Interventions
DRUG

EPB-348

Treated over seven days

DRUG

Valacyclovir

Treated over seven days

Trial Locations (1)

77030

Center for Clinical Studies-Medical Center, Houston

Sponsors
All Listed Sponsors
lead

Epiphany Biosciences

INDUSTRY